Pediatric lung transplant is a viable option for treatment of end-stage lung disease in children, with > 100 pediatric lung transplants reported to the Registry of the International Society of Heart and Lung Transplantation each year. Early referral to a transplant center is necessary and encouraged. Long-term success is limited by availability of donor organs, debilitation as a result of chronic disease, impaired mucus clearance resulting from both surgical and pharmacologic interventions, increased risk for infection resulting from immunosuppression, and most importantly late complications, such as chronic lung allograft dysfunction.
- Understand when to refer patients to a transplant center for evaluation for lung transplant
- Understand the indications for pediatric lung transplantation
- Understand the outcomes and survival after pediatric lung transplantation
ACCME Accreditation Statement: Children’s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement: Children's Hospital of Philadelphia designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement: Maureen Josephson, DO (Speaker), Wai Wong, MD (Moderator), Katie Lockwood, MD MEd, (CHOP Talks Course Director), and Monica S. Williams (CME Planner) and others as appropriate have no relevant financial relationship with a commercial interest to disclose.
Related specialties: pulmonology, transplant